GRI Bio (GRI) Short Interest Ratio & Short Volume $1.32 +0.04 (+3.13%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRI Bio Short Interest DataGRI Bio (GRI) has a short interest of 128,900 shares, representing 5.16% of the float (the number of shares available for trading by the public). This marks a 121.48% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 279,703 shares to cover all short positions.Current Short Interest128,900 sharesPrevious Short Interest58,200 sharesChange Vs. Previous Month+121.48%Dollar Volume Sold Short$232.02 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares2,500,000 sharesFloat Size2,500,000 sharesShort Percent of Float5.16%Today's Trading Volume279,984 sharesAverage Trading Volume279,703 sharesToday's Volume Vs. Average100% Short Selling GRI Bio? Sign up to receive the latest short interest report for GRI Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGRI Short Interest Over TimeGRI Days to Cover Over TimeGRI Percentage of Float Shorted Over Time GRI Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025128,900 shares $232.02 thousand +121.5%5.2%0.5 $1.80 6/30/202558,200 shares $75.08 thousand -4.0%2.5%0.2 $1.29 6/15/202560,600 shares $78.78 thousand -53.2%2.6%0.1 $1.30 5/31/2025129,600 shares $180.14 thousand +98.5%5.5%0.3 $1.39 5/15/202565,300 shares $94.69 thousand -37.8%2.8%0.1 $1.45 4/30/2025105,000 shares $191.10 thousand -58.3%5.5%0.3 $1.82 4/15/2025251,600 shares $395.01 thousand +281.8%34.6%0.8 $1.57 3/31/202565,900 shares $210.88 thousand +239.7%9.1%0.2 $3.20 3/15/202519,400 shares $116.21 thousand -29.2%3.7%1.3 $5.99 2/28/202527,400 shares $217.01 thousand +15.1%5.2%1.9 $7.92 Get the Latest News and Ratings for GRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GRI Bio and its competitors with MarketBeat's FREE daily newsletter. 2/15/202523,800 shares $222.53 thousand -93.2%0.3%1.5 $9.35 1/31/2025348,600 shares $220.32 thousand +1.0%3.9%1.2 $0.63 1/15/2025345,000 shares $253.06 thousand +26.5%3.9%0.2 $0.73 12/31/2024272,800 shares $225.99 thousand -12.5%3.1%0.1 $0.83 12/15/2024311,700 shares $249.36 thousand +155.5%3.5%0.1 $0.80 11/30/2024122,000 shares $83.39 thousand -40.8%1.4%0 $0.68 11/15/2024206,000 shares $159.05 thousand -77.7%2.3%0 $0.77 10/31/2024924,600 shares $811.80 thousand +309.5%31.7%0.2 $0.88 10/15/2024225,800 shares $83.55 thousand +33.5%7.7%0.1 $0.37 9/30/2024169,100 shares $60.88 thousand +17.7%5.8%0.2 $0.36 9/15/2024143,700 shares $72.21 thousand -67.2%4.9%0.2 $0.50 8/31/2024438,400 shares $222.53 thousand +15,557.1%15.0%0.7 $0.51 8/15/20242,800 shares $1.34 thousand -96.6%0.1%0 $0.48 7/31/202483,400 shares $63.83 thousand -0.7%2.9%0.2 $0.77 7/15/202484,000 shares $142.80 thousand +1.2%14.1%0.2 $1.70 6/30/202483,000 shares $159.36 thousand +6,284.6%14.0%0.7 $1.92 6/15/20241,300 shares $3.85 thousand -98.2%0.5%0 $2.96 5/31/202471,500 shares $21.59 thousand +194.2%1.9%0.2 $0.30 5/15/202424,300 shares $9.74 thousand +49.1%0.7%0.1 $0.40 4/30/202416,300 shares $6.98 thousand -10.9%0.5%0.1 $0.43 4/15/202418,300 shares $9.70 thousand -66.2%0.6%0 $0.53 3/31/202454,200 shares $41.19 thousand -53.2%1.8%0.1 $0.76 3/15/2024115,700 shares $89.40 thousand -19.3%12.6%0.2 $0.77 2/29/2024143,400 shares $114.79 thousand +671.0%16.2%0.2 $0.80 2/15/202418,600 shares $19.72 thousand -64.7%2.1%0 $1.06 1/31/202452,700 shares $85.37 thousand +137.4%6.0%0.1 $1.62 1/15/2024155,400 shares $48.98 thousand +7.0%3.8%0.4 $0.32 12/31/2023145,300 shares $55.94 thousand -13.2%3.6%0.4 $0.39 12/15/2023167,400 shares $73.59 thousand +194.2%4.6%0.4 $0.44 11/30/202356,900 shares $34.71 thousand +89.7%2.3%0.1 $0.61A new rule goes live in July — and the banks are quietly crushing it (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 11/15/202330,000 shares $33.30 thousand -40.7%1.2%0.2 $1.11 10/31/202350,600 shares $61.73 thousand -11.5%2.2%0.3 $1.22 10/15/202357,200 shares $85.23 thousand -15.6%2.5%0.4 $1.49 9/30/202367,800 shares $105.09 thousand +1.4%3.0%0.6 $1.55 9/15/202366,900 shares $93.66 thousand +1.4%2.9%0.6 $1.40 8/31/202366,000 shares $83.82 thousand +331.4%2.9%0.7 $1.27 8/15/202315,300 shares $41.00 thousand +378.1%0.7%0.3 $2.68 7/31/20233,200 shares $11.49 thousand -57.3%0.1%0.2 $3.59 7/15/20237,500 shares $30.23 thousand -36.4%0.3%0.3 $4.03 6/30/202311,800 shares $50.15 thousand -43.8%0.5%0.4 $4.25 6/15/202321,000 shares $128.52 thousand +17.3%0.9%0.7 $6.12 5/31/202317,900 shares $106.86 thousand -20.1%0.8%0.6 $5.97 5/15/202322,400 shares $142.02 thousand No Change0.8%0.6 $6.34 GRI Short Interest - Frequently Asked Questions What is GRI Bio's current short interest? Short interest is the volume of GRI Bio shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 128,900 shares of GRI short. 5.16% of GRI Bio's shares are currently sold short. Learn More on GRI Bio's current short interest. What is a good short interest percentage for GRI Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.16% of GRI Bio's floating shares are currently sold short. Is GRI Bio's short interest increasing or decreasing? GRI Bio saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 128,900 shares, an increase of 121.5% from the previous total of 58,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GRI Bio's float size? GRI Bio currently has issued a total of 2,500,000 shares. Some of GRI Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GRI Bio currently has a public float of 2,500,000 shares. How does GRI Bio's short interest compare to its competitors? 5.16% of GRI Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to GRI Bio: ProPhase Labs, Inc. (0.35%), Lexaria Bioscience Corp. (2.92%), Synlogic, Inc. (0.40%), Lipocine Inc. (1.93%), CASI Pharmaceuticals Inc. (0.70%), BioLineRx Ltd. (4.48%), 180 Life Sciences Corp. (1.89%), Athira Pharma, Inc. (3.08%), Citius Pharmaceuticals, Inc. (10.64%), MARKER THERAPEUTICS, INC. (1.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short GRI Bio stock? Short selling GRI is an investing strategy that aims to generate trading profit from GRI Bio as its price is falling. GRI shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GRI Bio? A short squeeze for GRI Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GRI, which in turn drives the price of the stock up even further. How often is GRI Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRI, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies PRPH Short Squeeze LEXX Short Squeeze SYBX Short Squeeze LPCN Short Squeeze CASI Short Squeeze BLRX Short Squeeze ATNF Short Squeeze ATHA Short Squeeze CTXR Short Squeeze MRKR Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GRI) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRI Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRI Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.